SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Shree Ganesh Biotech (India) L

BSE: 539470 19 Aug 2025
Healthcare
₹ 0.78
Shree Ganesh Biotech (India) Limited specializes in Biotechnology within the Healthcare sector.

Shree Ganesh Biotech (India) L - Share Price & Details

Market Cap
₹31.1
High /Low
1.25 / 0.77
Stock P/E
66.2
Book Value
₹1.59
Dividend Yield
0.0
ROCE
0.62
ROE
₹0.44
Face Value
1.0
PEG Ratio
-1.27
EVEBITDA
₹66.1
Debt
0.00
CMP / FCF
8.89
Debt to equity
₹0.0
NP Ann
0.28
High price all time
24.7
Piotroski score
₹4.0
Graham Number
0.65
No. Eq. Shares
39.9
Net CF
₹-0.41
Net profit
0.47
Price to book value
0.49
Interest Coverage
₹NA
Low price all time
0.7
Industry PE
63.8
Reserves
₹23.4
Free Cash Flow
₹-10.2

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
Shree Ganesh Biotech (India) L34.71-9.4630.06-0.0231.166.2
GUJARAT INJECT (KERALA) LTD.42.480.7342.370.0530.731.9
KK Shah Hospitals LimitedNANANANA30.3

Peer Comparison Chart


About Shree Ganesh Biotech (India) L

Shree Ganesh Biotech (India) Limited, with Security Code 539470, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Shree Ganesh Biotech Faces Financial Struggles Amid Significant Stock Decline

(30 Jul 2025)
Shree Ganesh Biotech India, a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a...
Read more →

ShreeGanesh Bio Standalone June 2025 Net Sales at Rs 1.38 crore, down 61.09% Y-o-Y

(30 Jul 2025)
Net Sales at Rs 1.38 crore in June 2025 down 61.09% from Rs. 3.56 crore in June 2024. Story continues below Advertisement.
Read more →

Shree Ganesh Biotech India standalone net profit rises 37.50% in the June 2025 quarter

(23 Jul 2025)
Net profit of Shree Ganesh Biotech India rose 37.50% to Rs 0.33 crore in the quarter ended June 2025 as against Rs 0.24 crore during the...
Read more →

Q1 results: Bajaj Finserv, Cipla, Bank of Baroda, SBI Cards, Shriram Finance, ACME Solar Holdings, others to post earnings on July 25; check list

(23 Jul 2025)
Q1 results: Chemicals maker Tata Chemicals, drugmaker Laurus Labs, consumer lending firm Poonawalla Fincorp, affordable housing finance firm...
Read more →

Q1 results today: Bajaj Finserv, Bank of Baroda, Cipla, others to declare quarterly earnings on Friday — 25 July 2025

(23 Jul 2025)
In total, over 100 listed companies are scheduled to announce their Q1FY26 results during the week starting from July 21.
Read more →

Shree Ganesh Biotech India reports standalone net loss of Rs 0.95 crore in the March 2025 quarter

(23 May 2025)
Sales decline 20.37% to Rs 3.01 crore. Net loss of Shree Ganesh Biotech India reported to Rs 0.95 crore in the quarter ended March 2025 as against net...
Read more →

Company Updates